Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mutation Burden”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Testing effectiveness (Phase 2)Looking for participantsNCT05093231
What this trial is testing

Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cambridge University Hospitals NHS Foundation Trust 20
Not applicableUnknownNCT04263688
What this trial is testing

Multicenter Observational Study of Advanced Non-small Cell Lung Cancer With Malignant Pleural Effusion

Who this might be right for
Non-Small Cell Lung Cancer
Guangzhou Institute of Respiratory Disease 300
Not applicableUnknownNCT04191226
What this trial is testing

Genetic Mutation in Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CancerNucleotide VariantCopy Number Variation+6 more
Lei Li 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT05197322
What this trial is testing

NEOadjuvant PembRolizumab In Stratified Medicine - ColoRectal Cancer

Who this might be right for
Adenocarcinoma of the Colon
University College, London 88
Not applicableUnknownNCT05199740
What this trial is testing

MtDNA Mutation Load Analysis in Mesoangioblasts

Who this might be right for
Mitochondrial Myopathies
Maastricht University 30
Not applicableUnknownNCT05993052
What this trial is testing

Carotid Plaque Burden in Patients With Philadelphia Negative Myeloproliferative Neoplasms

Who this might be right for
Myeloproliferative Neoplasm
Sohag University 100
Not applicableUnknownNCT03373955
What this trial is testing

A Prospective Study of Constructing Immune Repertoire to Monitor the Therapeutic Effect in NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Sichuan University 60
Not applicableStudy completedNCT03828422
What this trial is testing

Arterial Function and Atherosclerosis in Essential Thrombocythemia

Who this might be right for
Atherosclerosis
University Medical Centre Ljubljana 82
Not applicableUnknownNCT05602337
What this trial is testing

A Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin Cancer

Who this might be right for
Melanoma and Other Malignant Neoplasms of Skin
DermTech 180
Not applicableLooking for participantsNCT06536257
What this trial is testing

Personalised Immunotherapy Platform

Who this might be right for
MelanomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+2 more
Melanoma Institute Australia 1,000
Not applicableUnknownNCT03546452
What this trial is testing

A Prospective Study to Evaluate the Consistency of Next-Generation Sequencing(NGS)-Panels by Using Malignant Hydrothorax Form NSCLC

Who this might be right for
Malignant HydrothoraxNSCLC
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)UnknownNCT03638297
What this trial is testing

PD-1 Antibody Combined With COX Inhibitor in MSI-H/dMMR or High TMB Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 29
Post-approval studies (Phase 4)Study completedNCT04059887
What this trial is testing

Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]

Who this might be right for
Lung Neoplasm Malignant
Chonnam National University Hospital 100
Not applicableStudy completedNCT05619978
What this trial is testing

French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 200
Not applicableLooking for participantsNCT05929365
What this trial is testing

Innovative Approach to Detect Recurrent Colorectal Lesions With Surveillance Via Mutation Analysis & Clinical Phenotype

Who this might be right for
Predictive Cancer Model
Military University Hospital, Prague 200
Testing effectiveness (Phase 2)Study completedNCT02311569
What this trial is testing

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

Who this might be right for
Myeloproliferative NeoplasmPrimary MyelofibrosisEssential Thrombocythemia+1 more
Swiss Cancer Institute 39
Not applicableStudy completedNCT03997747
What this trial is testing

Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS

Who this might be right for
Osteosarcoma
Peking University People's Hospital 38
Testing effectiveness (Phase 2)Study completedNCT04098068
What this trial is testing

Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D)

Who this might be right for
High Tumor Mutation BurdenHigh TMB (Tumor Mutation Burden)MSS (Microsatellite Stable)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Testing effectiveness (Phase 2)Study completedNCT03836066
What this trial is testing

Atezolizumab Plus Bevacizumab in First Line NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Fundación GECP 41
Not applicableUnknownNCT04191252
What this trial is testing

Genetic Mutation in Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerNucleotide VariantCopy Number Variation+6 more
Lei Li 500
Next Page